List of Tables
Table 1. Global Starch Derivative Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Starch Derivative Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Starch Derivative Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Starch Derivative Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Starch Derivative Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Starch Derivative Excipient Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Starch Derivative Excipient Sales by Region (2020-2025) & (Tons)
Table 8. Global Starch Derivative Excipient Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Starch Derivative Excipient Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Starch Derivative Excipient Production by Region (2020-2025) & (Tons)
Table 12. Global Starch Derivative Excipient Production by Region (2026-2031) & (Tons)
Table 13. Global Starch Derivative Excipient Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Starch Derivative Excipient Sales Share by Manufacturers (2020-2025)
Table 15. Global Starch Derivative Excipient Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Starch Derivative Excipient Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Starch Derivative Excipient by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Starch Derivative Excipient as of 2024)
Table 19. Global Starch Derivative Excipient Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Starch Derivative Excipient Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Starch Derivative Excipient Manufacturing Base and Headquarters
Table 22. Global Starch Derivative Excipient Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Starch Derivative Excipient Sales by Type (2020-2025) & (Tons)
Table 26. Global Starch Derivative Excipient Sales by Type (2026-2031) & (Tons)
Table 27. Global Starch Derivative Excipient Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Starch Derivative Excipient Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Starch Derivative Excipient ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Starch Derivative Excipient Sales by Application (2020-2025) & (Tons)
Table 32. Global Starch Derivative Excipient Sales by Application (2026-2031) & (Tons)
Table 33. Starch Derivative Excipient High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Starch Derivative Excipient Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Starch Derivative Excipient Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Starch Derivative Excipient ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Starch Derivative Excipient Growth Accelerators and Market Barriers
Table 40. North America Starch Derivative Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Starch Derivative Excipient Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Starch Derivative Excipient Growth Accelerators and Market Barriers
Table 43. Europe Starch Derivative Excipient Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Starch Derivative Excipient Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Starch Derivative Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Starch Derivative Excipient Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Starch Derivative Excipient Growth Accelerators and Market Barriers
Table 48. Southeast Asia Starch Derivative Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Starch Derivative Excipient Investment Opportunities and Key Challenges
Table 50. Central and South America Starch Derivative Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Starch Derivative Excipient Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Starch Derivative Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Asahi Kasei Corporation Corporation Information
Table 54. Asahi Kasei Corporation Description and Major Businesses
Table 55. Asahi Kasei Corporation Product Models, Descriptions and Specifications
Table 56. Asahi Kasei Corporation Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Asahi Kasei Corporation Sales Value Proportion by Product in 2024
Table 58. Asahi Kasei Corporation Sales Value Proportion by Application in 2024
Table 59. Asahi Kasei Corporation Sales Value Proportion by Geographic Area in 2024
Table 60. Asahi Kasei Corporation Starch Derivative Excipient SWOT Analysis
Table 61. Asahi Kasei Corporation Recent Developments
Table 62. Cargill Corporation Information
Table 63. Cargill Description and Major Businesses
Table 64. Cargill Product Models, Descriptions and Specifications
Table 65. Cargill Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Cargill Sales Value Proportion by Product in 2024
Table 67. Cargill Sales Value Proportion by Application in 2024
Table 68. Cargill Sales Value Proportion by Geographic Area in 2024
Table 69. Cargill Starch Derivative Excipient SWOT Analysis
Table 70. Cargill Recent Developments
Table 71. Anhui Sunhere Pharmaceutical Excipients Co Corporation Information
Table 72. Anhui Sunhere Pharmaceutical Excipients Co Description and Major Businesses
Table 73. Anhui Sunhere Pharmaceutical Excipients Co Product Models, Descriptions and Specifications
Table 74. Anhui Sunhere Pharmaceutical Excipients Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Anhui Sunhere Pharmaceutical Excipients Co Sales Value Proportion by Product in 2024
Table 76. Anhui Sunhere Pharmaceutical Excipients Co Sales Value Proportion by Application in 2024
Table 77. Anhui Sunhere Pharmaceutical Excipients Co Sales Value Proportion by Geographic Area in 2024
Table 78. Anhui Sunhere Pharmaceutical Excipients Co Starch Derivative Excipient SWOT Analysis
Table 79. Anhui Sunhere Pharmaceutical Excipients Co Recent Developments
Table 80. Roquette Corporation Information
Table 81. Roquette Description and Major Businesses
Table 82. Roquette Product Models, Descriptions and Specifications
Table 83. Roquette Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Roquette Sales Value Proportion by Product in 2024
Table 85. Roquette Sales Value Proportion by Application in 2024
Table 86. Roquette Sales Value Proportion by Geographic Area in 2024
Table 87. Roquette Starch Derivative Excipient SWOT Analysis
Table 88. Roquette Recent Developments
Table 89. DFE Pharma Corporation Information
Table 90. DFE Pharma Description and Major Businesses
Table 91. DFE Pharma Product Models, Descriptions and Specifications
Table 92. DFE Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. DFE Pharma Sales Value Proportion by Product in 2024
Table 94. DFE Pharma Sales Value Proportion by Application in 2024
Table 95. DFE Pharma Sales Value Proportion by Geographic Area in 2024
Table 96. DFE Pharma Starch Derivative Excipient SWOT Analysis
Table 97. DFE Pharma Recent Developments
Table 98. Colorcon Corporation Information
Table 99. Colorcon Description and Major Businesses
Table 100. Colorcon Product Models, Descriptions and Specifications
Table 101. Colorcon Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Colorcon Recent Developments
Table 103. Wacker Corporation Information
Table 104. Wacker Description and Major Businesses
Table 105. Wacker Product Models, Descriptions and Specifications
Table 106. Wacker Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Wacker Recent Developments
Table 108. Shandong Xinda Biological Technology Co Corporation Information
Table 109. Shandong Xinda Biological Technology Co Description and Major Businesses
Table 110. Shandong Xinda Biological Technology Co Product Models, Descriptions and Specifications
Table 111. Shandong Xinda Biological Technology Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Shandong Xinda Biological Technology Co Recent Developments
Table 113. Huzhou Zhanwang Pharmaceutical Co Corporation Information
Table 114. Huzhou Zhanwang Pharmaceutical Co Description and Major Businesses
Table 115. Huzhou Zhanwang Pharmaceutical Co Product Models, Descriptions and Specifications
Table 116. Huzhou Zhanwang Pharmaceutical Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Huzhou Zhanwang Pharmaceutical Co Recent Developments
Table 118. Qufu Tianli Medical Corporation Information
Table 119. Qufu Tianli Medical Description and Major Businesses
Table 120. Qufu Tianli Medical Product Models, Descriptions and Specifications
Table 121. Qufu Tianli Medical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Qufu Tianli Medical Recent Developments
Table 123. Agrana Group Corporation Information
Table 124. Agrana Group Description and Major Businesses
Table 125. Agrana Group Product Models, Descriptions and Specifications
Table 126. Agrana Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Agrana Group Recent Developments
Table 128. Emsland Group Corporation Information
Table 129. Emsland Group Description and Major Businesses
Table 130. Emsland Group Product Models, Descriptions and Specifications
Table 131. Emsland Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Emsland Group Recent Developments
Table 133. Shandong Liaocheng E Hua Pharmaceutical Co Corporation Information
Table 134. Shandong Liaocheng E Hua Pharmaceutical Co Description and Major Businesses
Table 135. Shandong Liaocheng E Hua Pharmaceutical Co Product Models, Descriptions and Specifications
Table 136. Shandong Liaocheng E Hua Pharmaceutical Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Shandong Liaocheng E Hua Pharmaceutical Co Recent Developments
Table 138. Jiangxi Yipusheng Pharmaceutical Co Corporation Information
Table 139. Jiangxi Yipusheng Pharmaceutical Co Description and Major Businesses
Table 140. Jiangxi Yipusheng Pharmaceutical Co Product Models, Descriptions and Specifications
Table 141. Jiangxi Yipusheng Pharmaceutical Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Jiangxi Yipusheng Pharmaceutical Co Recent Developments
Table 143. Patel Chem Specialties Pvt Ltd Corporation Information
Table 144. Patel Chem Specialties Pvt Ltd Description and Major Businesses
Table 145. Patel Chem Specialties Pvt Ltd Product Models, Descriptions and Specifications
Table 146. Patel Chem Specialties Pvt Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Patel Chem Specialties Pvt Ltd Recent Developments
Table 148. Zibo Qianhui Biological Technology Co Corporation Information
Table 149. Zibo Qianhui Biological Technology Co Description and Major Businesses
Table 150. Zibo Qianhui Biological Technology Co Product Models, Descriptions and Specifications
Table 151. Zibo Qianhui Biological Technology Co Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. Zibo Qianhui Biological Technology Co Recent Developments
Table 153. Bluecraft Agro Corporation Information
Table 154. Bluecraft Agro Description and Major Businesses
Table 155. Bluecraft Agro Product Models, Descriptions and Specifications
Table 156. Bluecraft Agro Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 157. Bluecraft Agro Recent Developments
Table 158. Key Raw Materials Distribution
Table 159. Raw Materials Key Suppliers
Table 160. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 161. Milestones in Production Technology Evolution
Table 162. Distributors List
Table 163. Market Trends and Market Evolution
Table 164. Market Drivers and Opportunities
Table 165. Market Challenges, Risks, and Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Starch Derivative Excipient Product Picture
Figure 2. Global Starch Derivative Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Maize Starch Product Picture
Figure 4. Dextrin Product Picture
Figure 5. Pregelatinized Starch Product Picture
Figure 6. Others Product Picture
Figure 7. Global Starch Derivative Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Tablet
Figure 9. Capsule
Figure 10. Others
Figure 11. Starch Derivative Excipient Report Years Considered
Figure 12. Global Starch Derivative Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 14. Global Starch Derivative Excipient Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Starch Derivative Excipient Revenue Market Share by Region (2020-2031)
Figure 16. Global Starch Derivative Excipient Sales (2020-2031) & (Tons)
Figure 17. Global Starch Derivative Excipient Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Starch Derivative Excipient Sales Market Share by Region (2020-2031)
Figure 19. Global Starch Derivative Excipient Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Starch Derivative Excipient Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Starch Derivative Excipient Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Starch Derivative Excipient Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Starch Derivative Excipient Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Starch Derivative Excipient Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Starch Derivative Excipient Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Starch Derivative Excipient Sales Volume Market Share in 2024
Figure 28. Global Starch Derivative Excipient Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Maize Starch Revenue Market Share by Manufacturer in 2024
Figure 31. Dextrin Revenue Market Share by Manufacturer in 2024
Figure 32. Pregelatinized Starch Revenue Market Share by Manufacturer in 2024
Figure 33. Others Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Starch Derivative Excipient Sales Market Share by Type (2020-2031)
Figure 37. Global Starch Derivative Excipient Revenue Market Share by Type (2020-2031)
Figure 38. Global Starch Derivative Excipient Sales Market Share by Application (2020-2031)
Figure 39. Global Starch Derivative Excipient Revenue Market Share by Application (2020-2031)
Figure 40. North America Starch Derivative Excipient Sales YoY (2020-2031) & (Tons)
Figure 41. North America Starch Derivative Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Starch Derivative Excipient Sales Revenue (US$ Million) in 2024
Figure 43. North America Starch Derivative Excipient Sales Volume (Tons) by Type (2020- 2031)
Figure 44. North America Starch Derivative Excipient Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Starch Derivative Excipient Sales Volume (Tons) by Application (2020-2031)
Figure 46. North America Starch Derivative Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Starch Derivative Excipient Sales YoY (2020-2031) & (Tons)
Figure 51. Europe Starch Derivative Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Starch Derivative Excipient Sales Revenue (US$ Million) in 2024
Figure 53. Europe Starch Derivative Excipient Sales Volume (Tons) by Type (2020-2031)
Figure 54. Europe Starch Derivative Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Starch Derivative Excipient Sales Volume (Tons) by Application (2020-2031)
Figure 56. Europe Starch Derivative Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 58. France Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Starch Derivative Excipient Sales YoY (2020-2031) & (Tons)
Figure 63. Asia-Pacific Starch Derivative Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Starch Derivative Excipient Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Starch Derivative Excipient Sales Volume (Tons) by Type (2020- 2031)
Figure 66. Asia-Pacific Starch Derivative Excipient Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Starch Derivative Excipient Sales Volume (Tons) by Application (2020-2031)
Figure 68. Asia-Pacific Starch Derivative Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 73. India Starch Derivative Excipient Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Starch Derivative Excipient Sales YoY (2020-2031) & (Tons)
Figure 75. Central and South America Starch Derivative Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Starch Derivative Excipient Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Starch Derivative Excipient Sales Volume (Tons) by Type (2021-2031)
Figure 78. Central and South America Starch Derivative Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Starch Derivative Excipient Sales Volume (Tons) by Application (2020-2031)
Figure 80. Central and South America Starch Derivative Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Starch Derivative Excipient Sales YoY (2020-2031) & (Tons)
Figure 84. Middle East and Africa Starch Derivative Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Starch Derivative Excipient Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Starch Derivative Excipient Sales Volume (Tons) by Type (2021-2031)
Figure 87. South America Starch Derivative Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Starch Derivative Excipient Sales Volume (Tons) by Application (2020-2031)
Figure 89. Middle East and Africa Starch Derivative Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Starch Derivative Excipient Revenue (2020-2025) & (US$ Million)
Figure 94. Starch Derivative Excipient Industry Chain Mapping
Figure 95. Regional Starch Derivative Excipient Manufacturing Base Distribution (%)
Figure 96. Starch Derivative Excipient Production Process
Figure 97. Regional Starch Derivative Excipient Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
